Nicola Medici

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod

G. Tedeschi, A. Gallo, G. Donnarumma, 2022, Journal of Neurology.

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod

G. Tedeschi, A. Gallo, G. Donnarumma, 2022, Journal of Neurology.